DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Aprepitant is a drug marketed by Glenmark Pharms Sa, Sandoz, and Torrent. and is included in three NDAs.
The generic ingredient in APREPITANT is aprepitant. There are twenty-six drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the aprepitant profile page.
A generic version of APREPITANT was approved as aprepitant by SANDOZ on September 24th, 2012.
Summary for APREPITANT
Recent Clinical Trials for APREPITANT
Identify potential brand extensions & 505(b)(2) entrants
|Shanghai Children's Medical Center||N/A|
|PlusVitech S.L.||Phase 2|
|ECONiX Araştırma Analiz ve Danışmanlık A.Ş.||Phase 2|